NO SERUMS
Moelans CB, de Ligt J, van der Groep P, Prins P, Besselink N, Hoogstraat M, ter Hoeve N, Lacle M, Kornegoor R, van der Pol C, de Leng W, Barbe E, van der Vegt B, Martens J, Bult P, Smits VT, Koudijs M, Nijman I, Voest E, Selenica P, Weigelt B, Reis-Filho J, van der Wall E, Cuppen E, van Diest PJ
Bei allen Therapie-Formen spielen untersttzende Massnahmen eine zentrale Rolle
So here are some of the most commonly reported ones from various peptide clinics: Water retention Redness/itching at the site of injection Tiredness Head rush Numbness Tingling For diabetics, possible loss of glycemic control The side effect profile tends to be slightly stronger compared to other therapeutic peptides
While all GLP-1 RAs have the exact mechanism of action, there are differences in formulation, dose, injection technique, and administration